European Medicines Agency
After tying with Milan in a third round of voting, Amsterdam will be the new home of the European Medicines Agency.
The U.K. government announced that former GlaxoSmithKline chief Sir Andrew Witty will head up new pathway to get med and tech onto the market quicker.
The EMA’s call for extra staff comes as it is bracing itself for the likely loss of employees when it moves from its current home in London.
EMA sounded the alarm after a staff survey found as few as 6% of its staff would move to some of the 19 cities vying to host it when it leaves London.
The spectacular rehabilitation of Aveo's cancer drug tivozanib continues with E.U. approval as a treatment for advanced kidney cancer.
Staffers are set to move to their new digs in east London in the middle of next year, shortly the EMA is scheduled to leave a neighboring building.
Sarepta offers Exondys 51 outside of the U.S. through a managed access program run by Clinigen, as an EMA decision is expected next year.
Officials at the EMA must now allay concerns their meetings with sponsors introduce a source of bias into their decision-making.
The U.K. has been closing the gap on life sciences sectors in Boston and San Francisco, but uncertainty caused by Brexit may undermine those efforts, said the BIA.
AstraZeneca EVP Mene Pangalos has laid out how he wants the next government to support the United Kingdom’s life sciences sector through Brexit.